Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2019 Filed Sep 17, 2019 20:07 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionCommon Stock, $1 par value | 180 | $31.26 | $5,626.80 |
DisclosureSEC source: 0001262931-19-000004 · edgar.xml · nonDerivative · entry 1 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Forsyth with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 20:15 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
SaleCommon Stock, $1 par value | 5,934 | $88.12 | $522,904.08 |
DisclosureSEC source: 0001779771-19-000008 · edgar.xml · nonDerivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,089 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Ms. Kunzler with respect to certain vested restricted stock units and performance share units, and previously exercised stock options granted by Baxter International Inc. to Ms. Kunzler. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 20:09 UTC |
Franzi CristianoSVP, President, EMEA
|
Tax withholdingCommon Stock, $1 par value | 402 | $87.78 | $35,287.56 |
DisclosureSEC source: 0001715790-19-000003 · edgar.xml · nonDerivative · entry 1 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,833 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the partial vesting of restricted stock units granted on September 3, 2019. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 20:07 UTC |
Accogli GiuseppeSVP, President, Americas
|
Tax withholdingCommon Stock, $1 par value | 2,285 | $87.78 | $200,577.30 |
DisclosureSEC source: 0001678067-19-000005 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · SVP, President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,730 F1 · price: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of restricted stock units granted on September 3, 2019. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,930 | $0.00 Strike: $36.93 | $0.00 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · derivative · entry 5 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,930 shares Expires 2023-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,020 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · derivative · entry 4 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,020 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC |
GAVIN JAMES R IIIDirector
|
SaleCommon Stock, $1 par value | 7,950 | $87.63 | $696,658.50 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · nonDerivative · entry 3 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,912 F1 · price: Price reflects weighted average sales price. Range of prices for transactions are $87.63 through $87.64. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionCommon Stock, $1 par value | 3,930 | $36.93 | $145,134.90 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · nonDerivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionCommon Stock, $1 par value | 4,020 | $29.52 | $118,670.40 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2019 Filed Jul 26, 2019 20:03 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 13 | $85.16 | $1,107.08 |
DisclosureSEC source: 0001779771-19-000007 · edgar.xml · derivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,652 Underlying: Common Stock, $1 par value · 13 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:02 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 13 | $82.53 | $1,072.89 |
DisclosureSEC source: 0001779771-19-000006 · edgar.xml · derivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,640 Underlying: Common Stock, $1 par value · 13 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:31 UTC |
Chen Thomas FDirector
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 52 | $81.58 | $4,242.16 |
DisclosureSEC source: 0001360147-19-000004 · edgar.xml · derivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,360 Underlying: Common Stock, $1 par value · 52 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:33 UTC |
GAVIN JAMES R IIIDirector
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 65 | $81.58 | $5,302.70 |
DisclosureSEC source: 0001220966-19-000004 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,803 Underlying: Common Stock, $1 par value · 65 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 20:17 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 13 | $81.67 | $1,061.71 |
DisclosureSEC source: 0001779771-19-000005 · edgar.xml · derivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618 Underlying: Common Stock Fund, $1 par value · 13 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:01 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
SaleCommon Stock, $1 par value | 593 | $80.46 | $47,712.78 |
DisclosureSEC source: 0001779771-19-000004 · edgar.xml · nonDerivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,023 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Ms. Kunzler with respect to certain restricted stock units granted by Baxter International Inc. ("BII") to Ms. Kunzler. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 20:07 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 14 | $78.21 | $1,094.94 |
DisclosureSEC source: 0001779771-19-000003 · edgar.xml · derivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,606 Underlying: Common Stock, $1 par value · 14 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 20:02 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,320 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001262931-19-000003 · edgar.xml · derivative · entry 3 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 1,320 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Forsyth with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 20:02 UTC |
FORSYTH JOHN DDirector
|
SaleCommon Stock, $1 par value | 1,320 | $78.21 | $103,237.20 |
DisclosureSEC source: 0001262931-19-000003 · edgar.xml · nonDerivative · entry 2 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,459 Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 20:02 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionCommon Stock, $1 par value | 1,320 | $24.27 | $32,036.40 |
DisclosureSEC source: 0001262931-19-000003 · edgar.xml · nonDerivative · entry 1 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Forsyth with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth. Read SEC document |
| May 16, 2019 Filed May 17, 2019 21:08 UTC |
Third Point LLCDirector · See Remarks
Loeb Daniel SDirector
|
SaleCommon Stock, par value $1.00 per share ("Common Stock") | 5,000,000 | $76.37 | $381,850,000.00 |
DisclosureSEC source: 0001567619-19-011563 · doc1.xml · nonDerivative · entry 1 Third Point LLC · CIK 0001040273 · Director · See Remarks Loeb Daniel S · CIK 0001300345 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 23,008,124.8167 F1 · balance_after: Includes (1) 6,290 stock options granted to Munib Islam which became exercisable on the date of the Issuer's 2016 annual meeting of stockholders at an exercise price of $32.85 and (2) 44.8167 shares accumulated from stock dividends on restricted stock units previously awarded to Mr. Islam. F2 · ownership.nature: Except as otherwise noted herein, the securities disclosed in this Form 4 are owned by certain funds (the "Funds") managed by Third Point LLC ("Third Point"). Daniel S. Loeb is the Chief Executive Officer of Third Point. By reason of the provisions of Rule 16a-l under the Securities Exchange Act of 1934, as amended, Third Point and Mr. Loeb may be deemed to be the beneficial owners of the securities beneficially owned by the Funds. Third Point and Mr. Loeb hereby disclaim beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:22 UTC |
GAVIN JAMES R IIIDirector
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 70 | $75.44 | $5,280.80 |
DisclosureSEC source: 0001220966-19-000003 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,714 Underlying: Common Stock, $1 par value · 70 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:20 UTC |
Chen Thomas FDirector
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 56 | $75.44 | $4,224.64 |
DisclosureSEC source: 0001360147-19-000003 · edgar.xml · derivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,301 Underlying: Common Stock, $1 par value · 56 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:15 UTC |
Wendell Amy McBrideDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001400568-19-000003 · edgar.xml · derivative · entry 2 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:15 UTC |
Wendell Amy McBrideDirector
|
GrantCommon Stock, $1 par value | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001400568-19-000003 · edgar.xml · nonDerivative · entry 1 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,650 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:13 UTC |
STALLKAMP THOMAS TDirector
|
GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001124165-19-000006 · edgar.xml · nonDerivative · entry 1 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,149 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:14 UTC |
STROUCKEN ALBERT P LDirector
|
GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001205438-19-000002 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,698 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:12 UTC |
Smith Cathy RDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001322028-19-000001 · edgar.xml · derivative · entry 2 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:12 UTC |
Smith Cathy RDirector
|
GrantCommon Stock, $1 par value | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001322028-19-000001 · edgar.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,020 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:11 UTC |
Oesterle Stephen N.Director
|
GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001174532-19-000001 · edgar.xml · nonDerivative · entry 1 Oesterle Stephen N. · CIK 0001174532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,842 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:10 UTC |
MORRISON PATRICIADirector
|
GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001204081-19-000007 · edgar.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,856 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:09 UTC |
Mahoney Michael FDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001533022-19-000001 · edgar.xml · derivative · entry 3 Mahoney Michael F · CIK 0001533022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:09 UTC |
Mahoney Michael FDirector
|
GrantCommon Stock, $1 par value | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001533022-19-000001 · edgar.xml · nonDerivative · entry 1 Mahoney Michael F · CIK 0001533022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,898 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:08 UTC |
HELLMAN PETER SDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001107468-19-000002 · edgar.xml · derivative · entry 3 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:08 UTC |
HELLMAN PETER SDirector
|
GrantCommon Stock, $1 par value | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001107468-19-000002 · edgar.xml · nonDerivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,300 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:07 UTC |
GAVIN JAMES R IIIDirector
|
GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001220966-19-000002 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,813 F1 · shares: Dr. Gavin elected to defer 100% of his 2019 annual equity grant in the form of fully vested Baxter International Inc. ("BII") common stock pursuant to the BII's Director's Deferred Compensation Plan, amended May 2019, and subject to the terms and conditions of such grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:06 UTC |
FORSYTH JOHN DDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001262931-19-000002 · edgar.xml · derivative · entry 2 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:06 UTC |
FORSYTH JOHN DDirector
|
GrantCommon Stock, $1 par value | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001262931-19-000002 · edgar.xml · nonDerivative · entry 1 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,459 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:04 UTC |
Chen Thomas FDirector
|
GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001360147-19-000002 · edgar.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,245 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:09 UTC |
STALLKAMP THOMAS TDirector
|
SaleCommon Stock, $1 par value | 1,000 | $76.20 | $76,200.00 |
DisclosureSEC source: 0001124165-19-000005 · edgar.xml · nonDerivative · entry 1 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,737 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stallkamp with respect to certain vested Restricted Stock Units previously granted by Baxter International Inc. to Mr. Stallkamp. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:33 UTC |
STROUCKEN ALBERT P LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,680 | $0.00 Strike: $26.78 | $0.00 |
DisclosureSEC source: 0001205438-19-000001 · edgar.xml · derivative · entry 4 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 5,680 shares Expires 2019-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options granted by Baxter International Inc. to Mr. Stroucken. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:33 UTC |
STROUCKEN ALBERT P LDirector
|
SaleCommon Stock, $1 par value | 5,680 | $81.89 | $465,135.20 |
DisclosureSEC source: 0001205438-19-000001 · edgar.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,285 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:33 UTC |
STROUCKEN ALBERT P LDirector
|
Exercise / conversionCommon Stock, $1 par valu | 5,680 | $26.78 | $152,110.40 |
DisclosureSEC source: 0001205438-19-000001 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options granted by Baxter International Inc. to Mr. Stroucken. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:31 UTC |
STALLKAMP THOMAS TDirector
|
SaleCommon Stock, $1 par value | 1,043 | $82.07 | $85,599.01 |
DisclosureSEC source: 0001124165-19-000004 · edgar.xml · nonDerivative · entry 1 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,737 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stallkamp with respect to certain vested Restricted Stock Units previously granted by Baxter International Inc. ("BII") to Mr. Stallkamp. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $81.95 through $82.09. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:30 UTC |
HELLMAN PETER SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,680 | $0.00 Strike: $26.78 | $0.00 |
DisclosureSEC source: 0001107468-19-000001 · edgar.xml · derivative · entry 4 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 5,680 shares Expires 2019-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Hellman with respect to certain vested stock options granted by Baxter International Inc. to Mr. Hellman. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:30 UTC |
HELLMAN PETER SDirector
|
SaleCommon Stock, $1 par value | 5,680 | $81.89 | $465,135.20 |
DisclosureSEC source: 0001107468-19-000001 · edgar.xml · nonDerivative · entry 2 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,094 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:30 UTC |
HELLMAN PETER SDirector
|
Exercise / conversionCommon Stock, $1 par value | 5,680 | $26.78 | $152,110.40 |
DisclosureSEC source: 0001107468-19-000001 · edgar.xml · nonDerivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Hellman with respect to certain vested stock options granted by Baxter International Inc. to Mr. Hellman. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:05 UTC |
Pleau ScottSVP, Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,710 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001678065-19-000003 · edgar.xml · derivative · entry 3 Pleau Scott · CIK 0001678065 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 9,710 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Pleau with respect to certain vested stock options granted by Baxter International Inc. ("BII") to Mr. Pleau. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:05 UTC |
Pleau ScottSVP, Operations
|
SaleCommon Stock, $1 par value | 9,710 | $80.00 | $776,800.00 |
DisclosureSEC source: 0001678065-19-000003 · edgar.xml · nonDerivative · entry 2 Pleau Scott · CIK 0001678065 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,076 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Pleau with respect to certain vested stock options granted by Baxter International Inc. ("BII") to Mr. Pleau. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $80.00 through $80.05. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:05 UTC |
Pleau ScottSVP, Operations
|
Exercise / conversionCommon Stock, $1 par value | 9,710 | $50.77 | $492,976.70 |
DisclosureSEC source: 0001678065-19-000003 · edgar.xml · nonDerivative · entry 1 Pleau Scott · CIK 0001678065 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Pleau with respect to certain vested stock options granted by Baxter International Inc. ("BII") to Mr. Pleau. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 20:59 UTC |
Accogli GiuseppeSVP, President, Global Bus.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,315 | $0.00 Strike: $39.33 | $0.00 |
DisclosureSEC source: 0001678067-19-000004 · edgar.xml · derivative · entry 8 Accogli Giuseppe · CIK 0001678067 · SVP, President, Global Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 9,315 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.